| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ALKS | Ordinary Shares | Options Exercise | +4.53K | +23.01% | 24.2K | 10 Feb 2024 | Direct | F1 | ||
| transaction | ALKS | Ordinary Shares | Tax liability | -$29.7K | -1.09K | -4.49% | $27.32 | 23.1K | 10 Feb 2024 | Direct | |
| holding | ALKS | Ordinary Shares | 80K | 10 Feb 2024 | By the Daglio Trust | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ALKS | Non Qualified Stock Option (Right to Buy) | Other | $2.02K | +90 | +1.98% | $22.48 | 4.64K | 17 Nov 2023 | Ordinary Shares | 90 | $22.48 | Direct | F3, F4 |
| transaction | ALKS | Non Qualified Stock Option (Right to Buy) | Other | $11.8K | +523 | +2% | $22.48 | 26.7K | 17 Nov 2023 | Ordinary Shares | 523 | $22.48 | Direct | F3, F4 |
| transaction | ALKS | Restricted Stock Unit Award | Other | +88 | +1.98% | 4.53K | 17 Nov 2023 | Ordinary Shares | 88 | Direct | F1, F3, F5 | |||
| transaction | ALKS | Non Qualified Stock Option (Right to Buy) | Other | $7.59K | +313 | +2% | $24.24 | 16K | 17 Nov 2023 | Ordinary Shares | 313 | $24.24 | Direct | F3, F4 |
| transaction | ALKS | Non Qualified Stock Option (Right to Buy) | Other | $7.13K | +231 | +2% | $30.86 | 11.8K | 17 Nov 2023 | Ordinary Shares | 231 | $30.86 | Direct | F3, F4 |
| transaction | ALKS | Non Qualified Stock Option (Right to Buy) | Other | $7.8K | +254 | +1.99% | $30.72 | 13K | 17 Nov 2023 | Ordinary Shares | 254 | $30.72 | Direct | F3, F6 |
| transaction | ALKS | Restricted Stock Unit Award | Other | +119 | +1.99% | 6.1K | 17 Nov 2023 | Ordinary Shares | 119 | Direct | F1, F3, F7 | |||
| transaction | ALKS | Restricted Stock Unit Award | Options Exercise | -4.53K | -100% | 0 | 10 Feb 2024 | Ordinary Shares | 4.53K | Direct | F1, F5 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit represents a contingent right to receive one ordinary share. |
| F2 | Shares are held by The David A Daglio Jr Trust U/A 09/21/17 (the "Daglio Trust"), of which the reporting person is both sole trustee and sole beneficiary. |
| F3 | Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the "Separation"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5. |
| F4 | These options are fully vested in accordance with their terms. |
| F5 | This award is fully vested in accordance with its terms. |
| F6 | Shares subject to the stock option award vest and become exercisable in full on 6/29/2024. |
| F7 | Shares subject to the restricted stock unit award vest in full on 6/29/2024. |